RU2017144631A3 - - Google Patents

Download PDF

Info

Publication number
RU2017144631A3
RU2017144631A3 RU2017144631A RU2017144631A RU2017144631A3 RU 2017144631 A3 RU2017144631 A3 RU 2017144631A3 RU 2017144631 A RU2017144631 A RU 2017144631A RU 2017144631 A RU2017144631 A RU 2017144631A RU 2017144631 A3 RU2017144631 A3 RU 2017144631A3
Authority
RU
Russia
Application number
RU2017144631A
Other languages
Russian (ru)
Other versions
RU2781141C2 (ru
RU2017144631A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46172304&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2017144631(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of RU2017144631A publication Critical patent/RU2017144631A/ru
Publication of RU2017144631A3 publication Critical patent/RU2017144631A3/ru
Application granted granted Critical
Publication of RU2781141C2 publication Critical patent/RU2781141C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00—Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
RU2017144631A 2010-12-03 2011-12-02 Повышение биодоступности лекарственных средств при терапии налтрексоном RU2781141C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41939510P 2010-12-03 2010-12-03
US61/419,395 2010-12-03

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2013127423A Division RU2640561C2 (ru) 2010-12-03 2011-12-02 Повышение биодоступности лекарственных средств при терапии налтрексоном

Publications (3)

Publication Number Publication Date
RU2017144631A RU2017144631A (ru) 2019-02-18
RU2017144631A3 true RU2017144631A3 (enExample) 2021-04-13
RU2781141C2 RU2781141C2 (ru) 2022-10-06

Family

ID=

Also Published As

Publication number Publication date
PT3884947T (pt) 2024-02-16
US20130245056A1 (en) 2013-09-19
KR20200044158A (ko) 2020-04-28
RS65198B1 (sr) 2024-03-29
HUE034393T2 (en) 2018-02-28
EP2646031A4 (en) 2014-04-23
TW201304780A (zh) 2013-02-01
KR20140035320A (ko) 2014-03-21
MX356801B (es) 2018-06-13
CN103313711A (zh) 2013-09-18
JP7025319B2 (ja) 2022-02-24
EP3884947A1 (en) 2021-09-29
MX2013006071A (es) 2013-10-01
AR093182A1 (es) 2015-05-27
PL3884947T3 (pl) 2024-05-06
KR101984500B1 (ko) 2019-05-31
AU2011336304B2 (en) 2017-03-30
IL270841A (en) 2020-01-30
KR20210063473A (ko) 2021-06-01
DK3884947T3 (da) 2024-01-22
EP2646031B1 (en) 2017-02-22
DK4349369T3 (da) 2025-12-22
DK2646031T3 (en) 2017-05-22
EP3222280A1 (en) 2017-09-27
CL2013001564A1 (es) 2014-05-02
KR102105857B1 (ko) 2020-05-04
HUE053831T2 (hu) 2021-07-28
BR112013013390A2 (pt) 2016-09-06
CA2819262A1 (en) 2012-06-07
RU2640561C2 (ru) 2018-01-09
JP2013544290A (ja) 2013-12-12
HRP20251576T1 (hr) 2026-01-30
LT3884947T (lt) 2024-03-12
JP2019056004A (ja) 2019-04-11
EP4696322A3 (en) 2026-04-15
IL330443A (en) 2026-08-01
AU2011336304A1 (en) 2013-07-11
ES3056642T3 (en) 2026-02-23
JP6008866B2 (ja) 2016-10-19
SMT201700232T1 (it) 2017-07-18
EP4349369A2 (en) 2024-04-10
LT4349369T (lt) 2026-01-12
KR102258043B1 (ko) 2021-05-28
KR102391511B1 (ko) 2022-04-26
SI2646031T1 (sl) 2017-07-31
WO2012075459A1 (en) 2012-06-07
HRP20240115T1 (hr) 2024-06-07
KR20180069089A (ko) 2018-06-22
FI4349369T3 (fi) 2025-12-17
KR20190058702A (ko) 2019-05-29
SI3222280T1 (sl) 2021-11-30
IL226504B (en) 2021-01-31
EP3884947B1 (en) 2023-11-15
ES2866879T3 (es) 2021-10-20
HRP20210618T1 (hr) 2021-09-17
JP2022060331A (ja) 2022-04-14
PL3222280T3 (pl) 2021-11-29
CA3239386A1 (en) 2012-06-07
LT2646031T (lt) 2017-06-26
JP2016210809A (ja) 2016-12-15
PT4349369T (pt) 2025-12-17
HUE065852T2 (hu) 2024-06-28
EP4696322A2 (en) 2026-02-18
ES2625527T9 (es) 2018-09-25
SMT202400038T1 (it) 2024-03-13
EP4349369B1 (en) 2025-09-17
CA2819262C (en) 2024-05-28
SI4349369T1 (sl) 2026-02-27
ES2625527T3 (es) 2017-07-19
CY1118968T1 (el) 2018-01-10
PL2646031T3 (pl) 2017-08-31
RS56014B1 (sr) 2017-09-29
FI3884947T3 (fi) 2024-01-30
EP2646031B9 (en) 2018-01-10
SMT202500474T1 (it) 2026-01-12
TWI618536B (zh) 2018-03-21
RU2013127423A (ru) 2015-01-10
PT2646031T (pt) 2017-05-25
JP2024071605A (ja) 2024-05-24
PT3222280T (pt) 2021-04-22
RS67527B1 (sr) 2026-01-30
AU2017204309A1 (en) 2017-07-13
EP2646031A1 (en) 2013-10-09
MX384662B (es) 2025-03-14
RU2017144631A (ru) 2019-02-18
SI3884947T1 (sl) 2024-06-28
EP3222280B1 (en) 2021-01-20
CY1124331T1 (el) 2022-07-22
EP4349369A3 (en) 2024-05-15
RS62149B1 (sr) 2021-08-31
AR124500A2 (es) 2023-04-05
JP6456890B2 (ja) 2019-01-23
LT3222280T (lt) 2021-05-10
DK3222280T3 (da) 2021-04-19
IL279626A (en) 2021-03-01
PL4349369T3 (pl) 2026-03-23
HRP20170734T1 (hr) 2017-08-11
SMT202100227T1 (it) 2021-07-12

Similar Documents

Publication Publication Date Title
BR112012030039A2 (enExample)
BR112012028408A2 (enExample)
BR112012029986A2 (enExample)
BR112012027808A2 (enExample)
BR112012024897A2 (enExample)
BR112012026492A2 (enExample)
BR112012017960A2 (enExample)
BR112012025482A2 (enExample)
BR112012031826A2 (enExample)
BR112012025577A2 (enExample)
BR112012023249A2 (enExample)
BR112012028186A2 (enExample)
BR112012016456A2 (enExample)
BR112012018256A2 (enExample)
BR112012025308A2 (enExample)
BR112012026403A2 (enExample)
BR112012027945A2 (enExample)
BR112012024872A2 (enExample)
BR112012023265A2 (enExample)
BR112013003284A2 (enExample)
BR112013002646A2 (enExample)
BR112012016895A2 (enExample)
BR112012028859A2 (enExample)
BR112012029562A2 (enExample)
BR112012027756A2 (enExample)